Searched for
COVISHIELD
ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwideCyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide aff...- Booster dose of Covishield offers best immune response: Lancet studyFor both binding and functional antibodies, in participants primed with Covishield, homologous boosting with Covishield offers better immun...
- SII's free supply of Covishield to Centre: First lot of 80 lakh doses set for dispatchAccording to an official source, Prakash Kumar Singh, Director - Government and Regulatory Affairs at Serum Institute of India, had written...
- Second Covishield dose can be given between 8-16 weeks after first dose, says NTAGI reducing gapPresently, the second dose of Covishield is given between 12-16 weeks after the first dose under the National COVID-19 Vaccination Strategy.
- Serum Institute of India applies for full market authorisation for CovishieldCovishield has been one of the main vaccines used in India for Covid-19. Around 90% people in India have got Covishield. The vaccine was gr...
- Government nod to commercial export of Covishield, Covaxin in view of sufficient stockThe government, earlier in October, had permitted the SII to export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh under th...
- Govt allows Serum Institute to export 50 lakh Covishield doses under COVAX to four nationsSII will commence Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishield on Nov...
- SII urges govt to fast-track movement of increasing Covishield stockPrakash Kumar Singh, Director, Government and Regulatory Affairs at SII, is learnt to have recently communicated to the Union Health Minist...
- Reducing gap between two doses of Covishield is being considered: SourcesThe government in May had further extended the gap between the two doses of Covishield from 6-8 weeks to 12-16 weeks and said the decision ...
- SII informs Centre it will supply around 20 crore Covishield doses in SeptemberSII's director had communicated that the production of Covishield would be ramped up to 10 crore each in August and September, sources said.
- No application for Covishield yet: EU drug regulatorThe EMA website lists four vaccines as under rolling review — Sputnik V, Covovax, CureVac and Sinovac. An SII executive who is familiar wit...
- Nine European countries accept Covishield for travel, say sourcesIndia has already asked the EU member countries to individually consider allowing Indians who have taken Covishield and Covaxin vaccines an...
- Covishield produces more antibodies than Covaxin, finds studyCovishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufa...
- Karnataka receives 3 lakh Covishield vaccines from CentreThe state government has placed an order of 3 crore vaccines comprising two crore Covishield and one crore Covaxin.
- Already booked online appointments for 2nd Covishield dose to remain valid, announces governmentThe Union government has reiterated to the states/UTs that online appointments booked for second dose of Covishield prior to this change of...
- Bombay HC rules in favour of Serum Institute in the trademark dispute for CovishieldA division bench of Justices Nitin Jamdar and C V Bhadang dismissed an appeal filed by pharmaceutical firm Cutis Biotech claiming trademark...
- ET Explains: Why did India extend the gap between Covishield vaccine doses?Covishield was okayed for emergency use by the DCGI in January. According to media reports yesterday, the Central government has ordered 12...
- Centre allays concerns on Covishield vaccineCovishield is safe and there is 'no signal of concern' regarding it as of now, the Centre asserted on Wednesday amid reports of possible si...
- Covishield not to be taken by people severely allergic to any of its ingredients: Serum InstituteAccording to the fact sheet for the vaccine recipient by the Serum Institute of India, one should not get the Covishield vaccine if the per...
- Covid-19: An FAQ factsheet for Covishield vaccine by Serum InstituteThe factsheet details information that would enable recipients to understand the benefits and common side-effects of the Covishield vaccine...
Load More
